Frank LaCreta

Apixaban, an oral, direct factor <scp>X</scp>a inhibitor: single dose safety, pharmacokinetics, pharmacodynamics and food effect in healthy subjects

Charles Frost, Jessie J. Wang, Sunil Nepal et al. · British Journal of Clinical Pharmacology · 2012 · 352 citations · Full text

Characterization of Renal Glucose Reabsorption in Response to Dapagliflozin in Healthy Subjects and Subjects With Type 2 Diabetes

Ralph A. DeFronzo, Marcus Hompesch, Sreeneeranj Kasichayanula et al. · Diabetes Care · 2013 · 281 citations · Full text

Safety, pharmacokinetics and pharmacodynamics of multiple oral doses of apixaban, a factor<scp>X</scp>a inhibitor, in healthy subjects

Charles Frost, Sunil Nepal, Jessie Wang et al. · British Journal of Clinical Pharmacology · 2013 · 277 citations · Full text

Differential Effects of Omeprazole and Pantoprazole on the Pharmacodynamics and Pharmacokinetics of Clopidogrel in Healthy Subjects: Randomized, Placebo-Controlled, Crossover Comparison Studies

Dominick J. Angiolillo, C. Michael Gibson, Shuk Han Cheng et al. · Clinical Pharmacology & Therapeutics · 2010 · 277 citations

Effect of extremes of body weight on the pharmacokinetics, pharmacodynamics, safety and tolerability of apixaban in healthy subjects

Vijay Upreti, Jessie Wang, Yu Chen Barrett et al. · British Journal of Clinical Pharmacology · 2013 · 268 citations · Full text